MedPath

Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease

Not Applicable
Not yet recruiting
Conditions
Copd
Interventions
Other: Sham Myofascial + Respiratory rehabilitation
Other: Experimental-Myofascial + Respiratory rehabilitation
Registration Number
NCT04260243
Lead Sponsor
Cardenal Herrera University
Brief Summary

The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).

Detailed Description

So far, there are no previous studies that analyze the effects of a myofascial relaxation protocol applied to the diaphragm within the respiratory rehabilitation treatment in patients with chronic obstructive pulmonary disease.

Aim: The main objective of this study is to assess the effects of a 3 weeks myofascial release protocol applied to the diaphragm on respiratory parameters in patients with chronic obstructive pulmonary disease.

Design: Randomized clinical trial

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • COPD;
  • Forced expiratory volume in the first second (FEV1) < 80%;
  • FEV1/Forced vital capacity (FVC) < 70%;
  • Maximal inspiratory pressure (MIP) < 70%.
Exclusion Criteria
  • Recent (6 months) spine or abdominal surgery;
  • Allergic status of any kind;
  • systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine diseases including diabetes, metabolic, and neoplastic syndromes);
  • neuromuscular or neurological injuries;
  • previous myofascial release treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham Myofascial + Respiratory rehabilitationSham Myofascial + Respiratory rehabilitationRespiratory rehabilitation programme + sham Myofascial Release
Experimental-Myofascial + Respiratory rehabilitationExperimental-Myofascial + Respiratory rehabilitationRespiratory rehabilitation programme + Myofascial Release
Primary Outcome Measures
NameTimeMethod
Quality of life measured with the Chronic Obstructive Pulmonary Disease Assessment Test: Score3 weeks

Score (0-40) higher scores mean a worse outcome.

Secondary Outcome Measures
NameTimeMethod
6 Minutes Walking Test3 weeks

Maximum distance reached

© Copyright 2025. All Rights Reserved by MedPath